A detailed history of Re Dickinson Investment Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Re Dickinson Investment Advisors, LLC holds 350 shares of BMY stock, worth $20,604. This represents 0.01% of its overall portfolio holdings.

Number of Shares
350
Previous 350 -0.0%
Holding current value
$20,604
Previous $14,000 28.57%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$48.48 - $57.85 $3,635 - $4,338
-75 Reduced 17.65%
350 $18,000
Q3 2023

Nov 14, 2023

BUY
$57.89 - $64.73 $4,341 - $4,854
75 Added 21.43%
425 $25,000
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $18,770 - $21,882
350 New
350 $22,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Re Dickinson Investment Advisors, LLC Portfolio

Follow Re Dickinson Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Re Dickinson Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Re Dickinson Investment Advisors, LLC with notifications on news.